山海药辅股东拟减持不超3%股份

Core Viewpoint - Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. plans to reduce its stake in Shanhe Pharmaceutical (300452) by up to 6.9787 million shares, representing no more than 3% of the company's total share capital within 90 days after a 15 trading day period from the announcement date [1] Group 1 - Fosun Pharmaceutical currently holds 21.6453 million shares in Shanhe Pharmaceutical, accounting for 9.23% of the company's total share capital [1]